The imipridone ONC201, a potent activator of the mitochondrial Clp protease proteolytic subunit (ClpP), was shown to inhibit cell proliferation and induce cell death in many cancers including GBM (35) and one DMG patient (36). The gene discussed is CLPP; the disease is glioblastoma.